| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | FAT4 DLL4 PCDH11Y GAS6 CASR CUBN LRP1B SVEP1 NELL1 EYS FBLN2 SULF2 CCBE1 VCAN JAG1 SLIT3 PCDH11X LRP1 PAM ATP2A2 AGRN PCDH7 PCDH9 FBN3 NOTCH1 NOTCH2 | 3.33e-14 | 749 | 110 | 26 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.94e-08 | 188 | 110 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.19e-04 | 268 | 110 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | structural molecule activity | FRAS1 KRT12 ANOS1 SRPX2 FBLN2 LLGL1 PXDN VCAN JAG1 BMPER MUC4 AGRN FBN3 MAPK8IP2 | 3.84e-04 | 891 | 110 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | Notch binding | 4.32e-04 | 27 | 110 | 3 | GO:0005112 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 2.65e-06 | 41 | 111 | 5 | GO:0035909 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 7.20e-06 | 50 | 111 | 5 | GO:1905314 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 2.26e-05 | 63 | 111 | 5 | GO:0003179 | |
| GeneOntologyBiologicalProcess | positive regulation of protein geranylgeranylation | 2.87e-05 | 2 | 111 | 2 | GO:2000541 | |
| GeneOntologyBiologicalProcess | regulation of protein geranylgeranylation | 2.87e-05 | 2 | 111 | 2 | GO:2000539 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 2.87e-05 | 2 | 111 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 4.94e-05 | 74 | 111 | 5 | GO:0010812 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 4.94e-05 | 74 | 111 | 5 | GO:0002011 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 5.65e-05 | 39 | 111 | 4 | GO:0003180 | |
| GeneOntologyBiologicalProcess | heart valve development | 6.37e-05 | 78 | 111 | 5 | GO:0003170 | |
| GeneOntologyBiologicalProcess | aorta development | 7.19e-05 | 80 | 111 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 8.58e-05 | 3 | 111 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic assembly at neuromuscular junction | 8.58e-05 | 3 | 111 | 2 | GO:0045887 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.09e-04 | 46 | 111 | 4 | GO:0003176 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 1.19e-04 | 47 | 111 | 4 | GO:0035850 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | DLL4 KAT6A ISM1 SRPX2 PXDN CCBE1 LPA JAG1 LRP1 BMPER EIF2AK3 NOTCH1 NOTCH2 SPINK5 | 1.25e-04 | 817 | 111 | 14 | GO:0048514 |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.40e-04 | 92 | 111 | 5 | GO:0048844 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 1.62e-04 | 20 | 111 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | positive regulation of motor neuron apoptotic process | 1.71e-04 | 4 | 111 | 2 | GO:2000673 | |
| GeneOntologyBiologicalProcess | response to follicle-stimulating hormone | 1.88e-04 | 21 | 111 | 3 | GO:0032354 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | FAT4 CRIM1 DLL4 GAS6 KCP CASR PPARGC1A SULF2 CCBE1 LRP1 KMT2A BMPER NOTCH1 NOTCH2 | 1.88e-04 | 850 | 111 | 14 | GO:0071363 |
| GeneOntologyBiologicalProcess | vasculature development | DLL4 KAT6A ISM1 SVEP1 SRPX2 PXDN CCBE1 LPA JAG1 LRP1 BMPER EIF2AK3 NOTCH1 NOTCH2 SPINK5 | 2.15e-04 | 969 | 111 | 15 | GO:0001944 |
| GeneOntologyBiologicalProcess | circulatory system development | FAT4 ATG7 DLL4 KAT6A ISM1 SVEP1 SRPX2 PXDN CCBE1 LPA VCAN JAG1 SLIT3 LRP1 BMPER EIF2AK3 NOTCH1 NOTCH2 SPINK5 | 2.37e-04 | 1442 | 111 | 19 | GO:0072359 |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 2.52e-04 | 57 | 111 | 4 | GO:0061005 | |
| GeneOntologyBiologicalProcess | behavioral fear response | 2.69e-04 | 58 | 111 | 4 | GO:0001662 | |
| GeneOntologyBiologicalProcess | response to growth factor | FAT4 CRIM1 DLL4 GAS6 KCP CASR PPARGC1A SULF2 CCBE1 LRP1 KMT2A BMPER NOTCH1 NOTCH2 | 2.78e-04 | 883 | 111 | 14 | GO:0070848 |
| GeneOntologyBiologicalProcess | pulmonary valve development | 2.83e-04 | 24 | 111 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 2.84e-04 | 5 | 111 | 2 | GO:0046967 | |
| GeneOntologyBiologicalProcess | positive regulation of neuromuscular junction development | 2.84e-04 | 5 | 111 | 2 | GO:1904398 | |
| GeneOntologyBiologicalProcess | behavioral defense response | 2.88e-04 | 59 | 111 | 4 | GO:0002209 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 3.22e-04 | 240 | 111 | 7 | GO:0070374 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | FAT4 DLL4 KAT6A ISM1 CASR SRPX2 PXDN CCBE1 LPA JAG1 LRP1 BMPER EIF2AK3 NOTCH1 NOTCH2 SPINK5 | 3.38e-04 | 1125 | 111 | 16 | GO:0035239 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 3.76e-04 | 410 | 111 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 4.24e-04 | 6 | 111 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 4.24e-04 | 6 | 111 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | angiogenesis | DLL4 ISM1 SRPX2 PXDN CCBE1 LPA JAG1 BMPER EIF2AK3 NOTCH1 NOTCH2 SPINK5 | 4.31e-04 | 708 | 111 | 12 | GO:0001525 |
| GeneOntologyBiologicalProcess | fear response | 4.43e-04 | 66 | 111 | 4 | GO:0042596 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 4.53e-04 | 254 | 111 | 7 | GO:0010810 | |
| GeneOntologyBiologicalProcess | blood vessel development | DLL4 KAT6A ISM1 SRPX2 PXDN CCBE1 LPA JAG1 LRP1 BMPER EIF2AK3 NOTCH1 NOTCH2 SPINK5 | 4.63e-04 | 929 | 111 | 14 | GO:0001568 |
| GeneOntologyBiologicalProcess | regulation of synaptic assembly at neuromuscular junction | 5.92e-04 | 7 | 111 | 2 | GO:0008582 | |
| GeneOntologyBiologicalProcess | response to gonadotropin | 6.71e-04 | 32 | 111 | 3 | GO:0034698 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular endothelial growth factor production | 6.71e-04 | 32 | 111 | 3 | GO:0010575 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 7.16e-04 | 131 | 111 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | artery development | 7.67e-04 | 133 | 111 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | protein geranylgeranylation | 7.87e-04 | 8 | 111 | 2 | GO:0018344 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 7.93e-04 | 134 | 111 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | glomerulus development | 7.95e-04 | 77 | 111 | 4 | GO:0032835 | |
| GeneOntologyCellularComponent | extracellular matrix | FRAS1 SVEP1 ANOS1 EYS SRPX2 FBLN2 FCGBP PXDN CCBE1 LPA VCAN BMPER MUC4 AGRN FBN3 | 2.26e-06 | 656 | 112 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FRAS1 SVEP1 ANOS1 EYS SRPX2 FBLN2 FCGBP PXDN CCBE1 LPA VCAN BMPER MUC4 AGRN FBN3 | 2.34e-06 | 658 | 112 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | apical part of cell | PAPPA2 MGAM FAT4 PLB1 CASR CUBN HAVCR1 FRMD6 JAG1 LRP1 MUC4 NOTCH1 | 8.00e-05 | 592 | 112 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | cell surface | GFRAL ADAM30 CASR CUBN HAVCR1 ANOS1 SRPX2 SULF2 PXDN LPA VCAN LRP1 PAM AGRN MUSK NOTCH1 NOTCH2 | 8.60e-05 | 1111 | 112 | 17 | GO:0009986 |
| GeneOntologyCellularComponent | apical plasma membrane | 2.91e-04 | 487 | 112 | 10 | GO:0016324 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 4.21e-04 | 6 | 112 | 2 | GO:0033165 | |
| GeneOntologyCellularComponent | sperm head | 5.47e-04 | 30 | 112 | 3 | GO:0061827 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 5.65e-04 | 530 | 112 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 9.99e-04 | 9 | 112 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.52e-03 | 11 | 112 | 2 | GO:0031094 | |
| HumanPheno | Abnormal rib cage morphology | FLNB FAT4 FRAS1 KAT6A CASR CCBE1 JAG1 ANKRD11 KMT2A BMPER AGRN EIF2AK3 MUSK | 7.32e-06 | 445 | 37 | 13 | HP:0001547 |
| HumanPheno | Thoracic hypoplasia | 1.02e-05 | 153 | 37 | 8 | HP:0005257 | |
| HumanPheno | Pericardial lymphangiectasia | 5.13e-05 | 2 | 37 | 2 | HP:0005183 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | TLK2 FAT4 FRAS1 CRIM1 ATG7 KAT6A AMBRA1 CASR BIRC6 NELL1 SULF2 LLGL1 VCAN LRP1 KMT2A PAM BMPER AGRN EIF2AK3 MUSK NOTCH2 SPINK5 | 5.78e-06 | 1269 | 86 | 22 | MP:0011111 |
| MousePheno | perinatal lethality, complete penetrance | FAT4 CRIM1 ATG7 KAT6A BIRC6 NELL1 SULF2 LLGL1 VCAN LRP1 KMT2A BMPER AGRN MUSK NOTCH2 SPINK5 | 5.93e-06 | 712 | 86 | 16 | MP:0011089 |
| MousePheno | decreased kidney cell proliferation | 1.84e-05 | 9 | 86 | 3 | MP:0011441 | |
| MousePheno | abnormal vertebral column morphology | PAPPA2 FLNB FAT4 FRAS1 CRIM1 KAT6A CASR NELL1 SULF2 ANKRD11 KMT2A BMPER EIF2AK3 MUSK NOTCH1 NOTCH2 | 2.07e-05 | 787 | 86 | 16 | MP:0004703 |
| MousePheno | abnormal blood circulation | FRAS1 CRIM1 DLL4 KAT6A BIRC6 PPARGC1A LLGL1 LPA VCAN JAG1 SLIT3 LRP1 KMT2A ATP2A2 NOTCH1 NOTCH2 | 4.92e-05 | 845 | 86 | 16 | MP:0002128 |
| MousePheno | abnormal blood vessel morphology | TLK2 FLNB FRAS1 CRIM1 DLL4 KAT6A ISM1 CUBN BIRC6 TMEFF2 PPARGC1A LLGL1 CCBE1 LPA VCAN JAG1 SLIT3 PAM BMPER ATP2A2 NOTCH1 NOTCH2 | 5.90e-05 | 1472 | 86 | 22 | MP:0001614 |
| MousePheno | abnormal vascular development | FLNB CRIM1 DLL4 KAT6A CUBN BIRC6 LPA VCAN JAG1 PAM ATP2A2 NOTCH1 | 1.14e-04 | 542 | 86 | 12 | MP:0000259 |
| MousePheno | abnormal vertebrae morphology | FLNB FAT4 FRAS1 CRIM1 KAT6A NELL1 SULF2 KMT2A BMPER EIF2AK3 NOTCH1 NOTCH2 | 1.22e-04 | 546 | 86 | 12 | MP:0000137 |
| MousePheno | abnormal posture | 1.23e-04 | 243 | 86 | 8 | MP:0001504 | |
| MousePheno | internal hemorrhage | 1.28e-04 | 387 | 86 | 10 | MP:0001634 | |
| MousePheno | perinatal lethality | FLNB FAT4 CRIM1 ATG7 KAT6A BIRC6 NELL1 SULF2 LLGL1 VCAN LRP1 KMT2A BMPER ATP2A2 AGRN MUSK NOTCH2 SPINK5 | 1.46e-04 | 1130 | 86 | 18 | MP:0002081 |
| MousePheno | limbs/digits/tail phenotype | PAPPA2 FLNB FAT4 FRAS1 CRIM1 KAT6A AMBRA1 SVEP1 PPARGC1A PXDN AFM VCAN LRP1 KMT2A PAPPA BMPER AGRN EIF2AK3 NOTCH2 | 1.86e-04 | 1258 | 86 | 19 | MP:0005371 |
| MousePheno | decreased bone mineral density of femur | 1.95e-04 | 47 | 86 | 4 | MP:0020010 | |
| MousePheno | hemorrhage | FRAS1 CRIM1 KAT6A BIRC6 LLGL1 LPA VCAN JAG1 SLIT3 LRP1 KMT2A NOTCH1 NOTCH2 | 1.97e-04 | 664 | 86 | 13 | MP:0001914 |
| MousePheno | enlarged parietal bone | 2.23e-04 | 4 | 86 | 2 | MP:0004421 | |
| MousePheno | fetal bleb | 2.23e-04 | 4 | 86 | 2 | MP:0008856 | |
| MousePheno | abnormal capillary morphology | 2.66e-04 | 93 | 86 | 5 | MP:0003658 | |
| MousePheno | small kidney | 2.73e-04 | 425 | 86 | 10 | MP:0002989 | |
| MousePheno | abnormal sternebra morphology | 2.89e-04 | 52 | 86 | 4 | MP:0004322 | |
| MousePheno | skin edema | 3.11e-04 | 53 | 86 | 4 | MP:0001786 | |
| MousePheno | lethality throughout fetal growth and development | 3.29e-04 | 435 | 86 | 10 | MP:0006208 | |
| MousePheno | neonatal lethality | FLNB FAT4 ATG7 KAT6A BIRC6 SULF2 LLGL1 VCAN BMPER ATP2A2 AGRN MUSK NOTCH2 SPINK5 | 3.45e-04 | 799 | 86 | 14 | MP:0002058 |
| MousePheno | abnormal extracellular matrix morphology | 3.73e-04 | 100 | 86 | 5 | MP:0013258 | |
| MousePheno | microphthalmia | 3.77e-04 | 362 | 86 | 9 | MP:0001297 | |
| MousePheno | abnormal kidney size | FAT4 FRAS1 CRIM1 ISM1 NELL1 PPARGC1A SULF2 ZBED4 LPA SLIT3 BMPER IGLON5 NOTCH2 | 3.99e-04 | 714 | 86 | 13 | MP:0002706 |
| MousePheno | neonatal lethality, complete penetrance | FAT4 ATG7 KAT6A BIRC6 SULF2 LLGL1 VCAN BMPER AGRN MUSK SPINK5 | 4.16e-04 | 534 | 86 | 11 | MP:0011087 |
| MousePheno | abnormal axial skeleton morphology | PAPPA2 FLNB FAT4 FRAS1 CRIM1 KAT6A ISM1 AMBRA1 CASR NELL1 SULF2 LLGL1 ANKRD11 DIP2C KMT2A BMPER EIF2AK3 MUSK NOTCH1 NOTCH2 | 4.38e-04 | 1458 | 86 | 20 | MP:0002114 |
| MousePheno | abnormal angiogenesis | 4.59e-04 | 372 | 86 | 9 | MP:0000260 | |
| MousePheno | abnormal vertebrae development | 4.70e-04 | 59 | 86 | 4 | MP:0005225 | |
| MousePheno | abnormal eye size | 4.86e-04 | 375 | 86 | 9 | MP:0002697 | |
| MousePheno | abnormal thoracic vertebrae morphology | 5.09e-04 | 107 | 86 | 5 | MP:0003047 | |
| MousePheno | abnormal kidney cell proliferation | 5.28e-04 | 26 | 86 | 3 | MP:0011439 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 5.52e-04 | 6 | 86 | 2 | MP:0001054 | |
| MousePheno | premature death | FLNB PMS2 POLE KAT6A CASR CUBN SULF2 LPA JAG1 SLIT3 KMT2A ATP2A2 AGRN MUSK NOTCH1 NOTCH2 | 6.00e-04 | 1051 | 86 | 16 | MP:0002083 |
| MousePheno | abnormal bone mineral density of femur | 6.03e-04 | 63 | 86 | 4 | MP:0020009 | |
| MousePheno | abnormal vitelline vasculature morphology | 6.04e-04 | 235 | 86 | 7 | MP:0003229 | |
| MousePheno | abnormal heart septum morphology | 6.22e-04 | 388 | 86 | 9 | MP:0006113 | |
| MousePheno | abnormal blood vessel physiology | 6.94e-04 | 394 | 86 | 9 | MP:0000249 | |
| MousePheno | decreased compact bone volume | 7.70e-04 | 7 | 86 | 2 | MP:0010965 | |
| MousePheno | abnormal tail morphology | 8.15e-04 | 403 | 86 | 9 | MP:0002111 | |
| MousePheno | abnormal vasculature physiology | 8.29e-04 | 404 | 86 | 9 | MP:0031170 | |
| MousePheno | edema | CRIM1 DLL4 KAT6A CASR BIRC6 SVEP1 CCBE1 KMT2A PAM ATP2A2 NOTCH2 | 8.40e-04 | 581 | 86 | 11 | MP:0001785 |
| MousePheno | abnormal lymphatic vessel morphology | 8.51e-04 | 69 | 86 | 4 | MP:0001879 | |
| Domain | EGF-like_dom | FAT4 FRAS1 DLL4 GAS6 ADAM30 CUBN LRP1B SVEP1 TMEFF2 NELL1 EYS FBLN2 FCGBP CCBE1 VCAN JAG1 SLIT3 LRP1 MUC4 AGRN FBN3 NOTCH1 NOTCH2 | 2.79e-21 | 249 | 110 | 23 | IPR000742 |
| Domain | EGF_CA | FAT4 DLL4 GAS6 CUBN LRP1B SVEP1 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 SLIT3 LRP1 AGRN FBN3 NOTCH1 NOTCH2 | 1.55e-20 | 122 | 110 | 18 | SM00179 |
| Domain | EGF | FAT4 FRAS1 DLL4 GAS6 CUBN LRP1B SVEP1 TMEFF2 NELL1 EYS FBLN2 FCGBP CCBE1 VCAN JAG1 SLIT3 LRP1 MUC4 AGRN FBN3 NOTCH1 NOTCH2 | 1.66e-20 | 235 | 110 | 22 | SM00181 |
| Domain | EGF-like_Ca-bd_dom | FAT4 DLL4 GAS6 CUBN LRP1B SVEP1 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 SLIT3 LRP1 AGRN FBN3 NOTCH1 NOTCH2 | 2.10e-20 | 124 | 110 | 18 | IPR001881 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FAT4 DLL4 GAS6 CUBN LRP1B SVEP1 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 SLIT3 LRP1 FBN3 NOTCH1 NOTCH2 | 4.33e-20 | 106 | 110 | 17 | IPR000152 |
| Domain | EGF_3 | FAT4 DLL4 GAS6 ADAM30 CUBN LRP1B SVEP1 TMEFF2 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 SLIT3 LRP1 MUC4 AGRN FBN3 NOTCH1 NOTCH2 | 3.54e-19 | 235 | 110 | 21 | PS50026 |
| Domain | EGF_Ca-bd_CS | FAT4 GAS6 CUBN LRP1B SVEP1 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 SLIT3 LRP1 FBN3 NOTCH1 NOTCH2 | 3.62e-19 | 97 | 110 | 16 | IPR018097 |
| Domain | EGF_CA | FAT4 GAS6 CUBN LRP1B SVEP1 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 SLIT3 LRP1 FBN3 NOTCH1 NOTCH2 | 5.11e-19 | 99 | 110 | 16 | PS01187 |
| Domain | ASX_HYDROXYL | FAT4 DLL4 GAS6 CUBN LRP1B SVEP1 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 LRP1 FBN3 NOTCH1 NOTCH2 | 6.05e-19 | 100 | 110 | 16 | PS00010 |
| Domain | EGF_1 | FAT4 DLL4 GAS6 ADAM30 CUBN LRP1B SVEP1 TMEFF2 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 SLIT3 LRP1 MUC4 AGRN FBN3 NOTCH1 NOTCH2 | 1.93e-18 | 255 | 110 | 21 | PS00022 |
| Domain | EGF-like_CS | FAT4 DLL4 GAS6 ADAM30 CUBN LRP1B SVEP1 TMEFF2 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 SLIT3 LRP1 MUC4 AGRN FBN3 NOTCH1 NOTCH2 | 3.12e-18 | 261 | 110 | 21 | IPR013032 |
| Domain | EGF_2 | FAT4 DLL4 GAS6 ADAM30 CUBN LRP1B SVEP1 TMEFF2 NELL1 EYS FBLN2 CCBE1 VCAN JAG1 SLIT3 LRP1 MUC4 AGRN FBN3 NOTCH1 NOTCH2 | 4.28e-18 | 265 | 110 | 21 | PS01186 |
| Domain | EGF | DLL4 GAS6 CUBN LRP1B SVEP1 TMEFF2 EYS VCAN JAG1 SLIT3 LRP1 MUC4 AGRN FBN3 NOTCH1 NOTCH2 | 2.84e-17 | 126 | 110 | 16 | PF00008 |
| Domain | Growth_fac_rcpt_ | FAT4 FRAS1 CRIM1 DLL4 GAS6 CUBN LRP1B SVEP1 NELL1 EYS FBLN2 JAG1 SLIT3 LRP1 FBN3 NOTCH1 NOTCH2 | 3.82e-17 | 156 | 110 | 17 | IPR009030 |
| Domain | EGF_CA | FAT4 GAS6 CUBN LRP1B SVEP1 NELL1 FBLN2 CCBE1 JAG1 LRP1 FBN3 NOTCH1 NOTCH2 | 3.01e-15 | 86 | 110 | 13 | PF07645 |
| Domain | hEGF | 3.15e-12 | 28 | 110 | 8 | PF12661 | |
| Domain | VWC | 4.72e-11 | 38 | 110 | 8 | SM00214 | |
| Domain | VWF_dom | 1.12e-10 | 42 | 110 | 8 | IPR001007 | |
| Domain | VWC_out | 9.27e-10 | 19 | 110 | 6 | SM00215 | |
| Domain | AMOP | 1.14e-09 | 4 | 110 | 4 | SM00723 | |
| Domain | AMOP | 1.14e-09 | 4 | 110 | 4 | PF03782 | |
| Domain | AMOP_dom | 1.14e-09 | 4 | 110 | 4 | IPR005533 | |
| Domain | AMOP | 1.14e-09 | 4 | 110 | 4 | PS50856 | |
| Domain | - | 4.71e-09 | 95 | 110 | 9 | 2.60.120.200 | |
| Domain | Protocadherin | 5.67e-09 | 5 | 110 | 4 | PF08374 | |
| Domain | Protocadherin | 5.67e-09 | 5 | 110 | 4 | IPR013585 | |
| Domain | VWC | 1.23e-08 | 28 | 110 | 6 | PF00093 | |
| Domain | VWF_type-D | 2.68e-08 | 16 | 110 | 5 | IPR001846 | |
| Domain | VWFD | 2.68e-08 | 16 | 110 | 5 | PS51233 | |
| Domain | VWD | 2.68e-08 | 16 | 110 | 5 | SM00216 | |
| Domain | VWD | 2.68e-08 | 16 | 110 | 5 | PF00094 | |
| Domain | Notch_dom | 3.93e-08 | 7 | 110 | 4 | IPR000800 | |
| Domain | Notch | 3.93e-08 | 7 | 110 | 4 | PF00066 | |
| Domain | NL | 3.93e-08 | 7 | 110 | 4 | SM00004 | |
| Domain | VWFC_1 | 6.14e-08 | 36 | 110 | 6 | PS01208 | |
| Domain | VWFC_2 | 8.61e-08 | 38 | 110 | 6 | PS50184 | |
| Domain | LamG | 2.14e-07 | 44 | 110 | 6 | SM00282 | |
| Domain | cEGF | 3.85e-07 | 26 | 110 | 5 | PF12662 | |
| Domain | cEGF | 3.85e-07 | 26 | 110 | 5 | IPR026823 | |
| Domain | Sushi | 5.94e-07 | 52 | 110 | 6 | PF00084 | |
| Domain | CCP | 7.47e-07 | 54 | 110 | 6 | SM00032 | |
| Domain | SUSHI | 9.30e-07 | 56 | 110 | 6 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.03e-06 | 57 | 110 | 6 | IPR000436 | |
| Domain | Laminin_G | 1.15e-06 | 58 | 110 | 6 | IPR001791 | |
| Domain | EGF_extracell | 1.41e-06 | 60 | 110 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.41e-06 | 60 | 110 | 6 | PF07974 | |
| Domain | LAM_G_DOMAIN | 2.78e-06 | 38 | 110 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 3.61e-06 | 40 | 110 | 5 | PF02210 | |
| Domain | ConA-like_dom | 5.92e-06 | 219 | 110 | 9 | IPR013320 | |
| Domain | Laminin_G_1 | 3.17e-05 | 11 | 110 | 3 | PF00054 | |
| Domain | Peptidase_M43 | 3.44e-05 | 2 | 110 | 2 | IPR008754 | |
| Domain | DUF5050 | 3.44e-05 | 2 | 110 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.44e-05 | 2 | 110 | 2 | PF16472 | |
| Domain | Peptidase_M43 | 3.44e-05 | 2 | 110 | 2 | PF05572 | |
| Domain | Unchr_dom_Cys-rich | 5.45e-05 | 13 | 110 | 3 | IPR014853 | |
| Domain | C8 | 5.45e-05 | 13 | 110 | 3 | SM00832 | |
| Domain | TIL_dom | 6.90e-05 | 14 | 110 | 3 | IPR002919 | |
| Domain | HYR | 1.03e-04 | 3 | 110 | 2 | PS50825 | |
| Domain | DUF3454 | 1.03e-04 | 3 | 110 | 2 | PF11936 | |
| Domain | Myxo_disulph_rpt | 1.03e-04 | 3 | 110 | 2 | IPR011936 | |
| Domain | HYR_dom | 1.03e-04 | 3 | 110 | 2 | IPR003410 | |
| Domain | DUF3454_notch | 1.03e-04 | 3 | 110 | 2 | IPR024600 | |
| Domain | HYR | 1.03e-04 | 3 | 110 | 2 | PF02494 | |
| Domain | P-type_ATPase_IIA | 1.03e-04 | 3 | 110 | 2 | IPR005782 | |
| Domain | DUF3454 | 1.03e-04 | 3 | 110 | 2 | SM01334 | |
| Domain | LamGL | 2.05e-04 | 4 | 110 | 2 | SM00560 | |
| Domain | Notch | 2.05e-04 | 4 | 110 | 2 | IPR008297 | |
| Domain | NODP | 2.05e-04 | 4 | 110 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 2.05e-04 | 4 | 110 | 2 | IPR011656 | |
| Domain | LamG-like | 2.05e-04 | 4 | 110 | 2 | IPR006558 | |
| Domain | DSL | 2.05e-04 | 4 | 110 | 2 | PF01414 | |
| Domain | Notch_NOD_dom | 2.05e-04 | 4 | 110 | 2 | IPR010660 | |
| Domain | NOD | 2.05e-04 | 4 | 110 | 2 | PF06816 | |
| Domain | DSL | 2.05e-04 | 4 | 110 | 2 | SM00051 | |
| Domain | NOD | 2.05e-04 | 4 | 110 | 2 | SM01338 | |
| Domain | NODP | 2.05e-04 | 4 | 110 | 2 | SM01339 | |
| Domain | Kazal_1 | 2.82e-04 | 22 | 110 | 3 | PF00050 | |
| Domain | DSL | 3.40e-04 | 5 | 110 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 3.40e-04 | 5 | 110 | 2 | IPR011651 | |
| Domain | MNNL | 3.40e-04 | 5 | 110 | 2 | PF07657 | |
| Domain | DSL | 3.40e-04 | 5 | 110 | 2 | IPR001774 | |
| Domain | LNR | 3.40e-04 | 5 | 110 | 2 | PS50258 | |
| Domain | Cadherin_CS | 4.65e-04 | 109 | 110 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 5.48e-04 | 113 | 110 | 5 | PS00232 | |
| Domain | Cadherin | 5.48e-04 | 113 | 110 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 5.70e-04 | 114 | 110 | 5 | PS50268 | |
| Domain | - | 5.70e-04 | 114 | 110 | 5 | 2.60.40.60 | |
| Domain | Cadherin_2 | 5.85e-04 | 65 | 110 | 4 | PF08266 | |
| Domain | Cadherin_N | 5.85e-04 | 65 | 110 | 4 | IPR013164 | |
| Domain | CA | 5.94e-04 | 115 | 110 | 5 | SM00112 | |
| Domain | Cadherin-like | 6.17e-04 | 116 | 110 | 5 | IPR015919 | |
| Domain | Cadherin | 6.67e-04 | 118 | 110 | 5 | IPR002126 | |
| Domain | Kazal_2 | 1.23e-03 | 36 | 110 | 3 | PF07648 | |
| Domain | NHL_repeat | 1.50e-03 | 10 | 110 | 2 | IPR001258 | |
| Domain | NHL | 1.50e-03 | 10 | 110 | 2 | PF01436 | |
| Domain | Hydrolase_3 | 1.50e-03 | 10 | 110 | 2 | PF08282 | |
| Domain | - | 1.56e-03 | 39 | 110 | 3 | 2.120.10.30 | |
| Domain | SET | 1.80e-03 | 41 | 110 | 3 | PF00856 | |
| Domain | Fol_N | 1.83e-03 | 11 | 110 | 2 | IPR003645 | |
| Domain | FOLN | 1.83e-03 | 11 | 110 | 2 | SM00274 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 6.29e-07 | 13 | 79 | 4 | M47423 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.63e-06 | 18 | 79 | 4 | M614 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 5.83e-06 | 7 | 79 | 3 | M27199 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.45e-05 | 27 | 79 | 4 | M39545 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 2.09e-05 | 60 | 79 | 5 | M40048 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.59e-05 | 12 | 79 | 3 | M47532 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 7.34e-05 | 15 | 79 | 3 | M27202 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 9.00e-05 | 16 | 79 | 3 | M47424 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.09e-04 | 17 | 79 | 3 | M39389 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.14e-04 | 45 | 79 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.25e-04 | 46 | 79 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.36e-04 | 47 | 79 | 4 | M7946 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.42e-04 | 22 | 79 | 3 | M27210 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 3.07e-04 | 5 | 79 | 2 | M27411 | |
| Pathway | PID_NOTCH_PATHWAY | 3.29e-04 | 59 | 79 | 4 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.74e-04 | 61 | 79 | 4 | M39540 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 4.58e-04 | 6 | 79 | 2 | M27068 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 6.80e-04 | 31 | 79 | 3 | M592 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 7.81e-04 | 74 | 79 | 4 | MM15962 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 8.19e-04 | 33 | 79 | 3 | M604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 8.49e-04 | 8 | 79 | 2 | M47955 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.09e-03 | 9 | 79 | 2 | M47866 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.15e-03 | 82 | 79 | 4 | MM15922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.15e-03 | 82 | 79 | 4 | M594 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.15e-03 | 37 | 79 | 3 | M39506 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.24e-03 | 143 | 79 | 5 | M27275 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.34e-03 | 39 | 79 | 3 | MM14604 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.44e-03 | 300 | 79 | 7 | M610 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.65e-03 | 11 | 79 | 2 | M47865 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.65e-03 | 11 | 79 | 2 | M27882 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.97e-03 | 12 | 79 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.97e-03 | 12 | 79 | 2 | M22042 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.97e-03 | 12 | 79 | 2 | M27326 | |
| Pathway | REACTOME_ALK_MUTANTS_BIND_TKIS | 1.97e-03 | 12 | 79 | 2 | M42522 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.97e-03 | 12 | 79 | 2 | M47533 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.03e-03 | 45 | 79 | 3 | MM15344 | |
| Pubmed | 5.08e-10 | 5 | 112 | 4 | 35064244 | ||
| Pubmed | 3.54e-09 | 7 | 112 | 4 | 32060138 | ||
| Pubmed | 3.55e-09 | 19 | 112 | 5 | 25691540 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 8.49e-09 | 248 | 112 | 10 | 24006456 | |
| Pubmed | 1.27e-08 | 9 | 112 | 4 | 16245338 | ||
| Pubmed | 1.27e-08 | 9 | 112 | 4 | 23095891 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.11e-08 | 10 | 112 | 4 | 23665443 | |
| Pubmed | 2.11e-08 | 10 | 112 | 4 | 24015274 | ||
| Pubmed | Reconstruction of phrenic neuron identity in embryonic stem cell-derived motor neurons. | 2.41e-08 | 27 | 112 | 5 | 24496616 | |
| Pubmed | A novel source of arterial valve cells linked to bicuspid aortic valve without raphe in mice. | 2.41e-08 | 27 | 112 | 5 | 29956664 | |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 20154142 | ||
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 21129452 | ||
| Pubmed | Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. | 3.25e-08 | 3 | 112 | 3 | 14726396 | |
| Pubmed | Helicobacter pylori Infection of Gastric Epithelial Cells Affects NOTCH Pathway In Vitro. | 3.25e-08 | 3 | 112 | 3 | 27073072 | |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 33351914 | ||
| Pubmed | delta-Protocadherins: a gene family expressed differentially in the mouse brain. | 3.30e-08 | 11 | 112 | 4 | 15905963 | |
| Pubmed | 4.94e-08 | 12 | 112 | 4 | 15465494 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FAT4 FRAS1 CRIM1 LYSMD3 LRP1B SULF2 PXDN LRP1 PAM BMPER ATP2A2 PLOD2 ATP2A3 AGRN PCDH7 EIF2AK3 NOTCH1 NOTCH2 | 5.68e-08 | 1201 | 112 | 18 | 35696571 |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 7.12e-08 | 13 | 112 | 4 | 11578869 | |
| Pubmed | 7.43e-08 | 167 | 112 | 8 | 22159717 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 9.51e-08 | 35 | 112 | 5 | 21252157 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FRAS1 POLE KAT6A AMBRA1 EXOSC8 FAAP100 BIRC6 DHX30 TLK1 ZBED4 ANKRD11 DIP2C ZNF839 ATP2A3 AGRN NOTCH1 NOTCH2 | 9.54e-08 | 1105 | 112 | 17 | 35748872 |
| Pubmed | 9.95e-08 | 14 | 112 | 4 | 14757642 | ||
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 1.30e-07 | 4 | 112 | 3 | 22390640 | |
| Pubmed | Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming. | 1.30e-07 | 4 | 112 | 3 | 30226866 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 10551863 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 30951556 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 36376768 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 24398584 | ||
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 1.30e-07 | 4 | 112 | 3 | 32820046 | |
| Pubmed | No evidence for a functional role of bi-directional Notch signaling during angiogenesis. | 1.30e-07 | 4 | 112 | 3 | 23300864 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 38462037 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 22020917 | ||
| Pubmed | 1.35e-07 | 15 | 112 | 4 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.80e-07 | 16 | 112 | 4 | 12617809 | |
| Pubmed | 1.80e-07 | 16 | 112 | 4 | 17273555 | ||
| Pubmed | 2.35e-07 | 17 | 112 | 4 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 2.35e-07 | 17 | 112 | 4 | 15821257 | |
| Pubmed | 3.01e-07 | 18 | 112 | 4 | 18093989 | ||
| Pubmed | 3.01e-07 | 18 | 112 | 4 | 38111957 | ||
| Pubmed | 3.01e-07 | 18 | 112 | 4 | 15689374 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 11713346 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 3.24e-07 | 5 | 112 | 3 | 15064243 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 23675950 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 15882997 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 30181175 | ||
| Pubmed | Notch signal strength controls cell fate in the haemogenic endothelium. | 3.24e-07 | 5 | 112 | 3 | 26465397 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 27118257 | ||
| Pubmed | 3.80e-07 | 19 | 112 | 4 | 20335360 | ||
| Pubmed | 3.80e-07 | 19 | 112 | 4 | 16518823 | ||
| Pubmed | Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. | 4.74e-07 | 20 | 112 | 4 | 23314057 | |
| Pubmed | 5.85e-07 | 21 | 112 | 4 | 28656980 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 10958687 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 6.46e-07 | 6 | 112 | 3 | 12244553 | |
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 15226394 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 17822320 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 22526456 | ||
| Pubmed | A central role for Notch in effector CD8(+) T cell differentiation. | 6.46e-07 | 6 | 112 | 3 | 25344724 | |
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 6.46e-07 | 6 | 112 | 3 | 19603167 | |
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 19217325 | ||
| Pubmed | Notch4 reveals a novel mechanism regulating Notch signal transduction. | 6.46e-07 | 6 | 112 | 3 | 24667410 | |
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 9108364 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 31071093 | ||
| Pubmed | 7.13e-07 | 22 | 112 | 4 | 21750033 | ||
| Pubmed | 8.61e-07 | 23 | 112 | 4 | 14701881 | ||
| Pubmed | Lunatic Fringe-mediated Notch signaling is required for lung alveogenesis. | 8.61e-07 | 23 | 112 | 4 | 19897741 | |
| Pubmed | 8.61e-07 | 23 | 112 | 4 | 36239412 | ||
| Pubmed | 1.03e-06 | 24 | 112 | 4 | 21633169 | ||
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 10383933 | ||
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 10079256 | ||
| Pubmed | Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. | 1.13e-06 | 7 | 112 | 3 | 27576369 | |
| Pubmed | Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate. | 1.13e-06 | 7 | 112 | 3 | 38383534 | |
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.13e-06 | 7 | 112 | 3 | 12846471 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 1.13e-06 | 7 | 112 | 3 | 24711412 | |
| Pubmed | Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. | 1.13e-06 | 7 | 112 | 3 | 21238454 | |
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 30289388 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 1.44e-06 | 26 | 112 | 4 | 19369401 | |
| Pubmed | 1.44e-06 | 26 | 112 | 4 | 32467237 | ||
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 1.69e-06 | 27 | 112 | 4 | 21791528 | |
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 1.80e-06 | 8 | 112 | 3 | 22652674 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 1.80e-06 | 8 | 112 | 3 | 15465493 | |
| Pubmed | Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. | 1.80e-06 | 8 | 112 | 3 | 24647000 | |
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 9858718 | ||
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 15068794 | ||
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 11044610 | ||
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 19914235 | ||
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 1.80e-06 | 8 | 112 | 3 | 12242716 | |
| Pubmed | 1.97e-06 | 28 | 112 | 4 | 35297995 | ||
| Pubmed | 2.27e-06 | 29 | 112 | 4 | 25535917 | ||
| Pubmed | 2.39e-06 | 118 | 112 | 6 | 21078624 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 2.62e-06 | 30 | 112 | 4 | 24552588 | |
| Pubmed | 2.69e-06 | 9 | 112 | 3 | 17573339 | ||
| Pubmed | Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. | 2.69e-06 | 9 | 112 | 3 | 11944948 | |
| Pubmed | Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. | 2.69e-06 | 9 | 112 | 3 | 17685488 | |
| Pubmed | 2.69e-06 | 9 | 112 | 3 | 23986861 | ||
| Pubmed | 2.69e-06 | 9 | 112 | 3 | 11118901 | ||
| Pubmed | Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. | 2.69e-06 | 9 | 112 | 3 | 28714968 | |
| Pubmed | Pax2 and Pax8 cooperate in mouse inner ear morphogenesis and innervation. | 2.69e-06 | 9 | 112 | 3 | 20727173 | |
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 2.69e-06 | 9 | 112 | 3 | 10837027 | |
| Interaction | IGFL3 interactions | 1.63e-07 | 75 | 109 | 7 | int:IGFL3 | |
| Interaction | NOTCH2 interactions | ZBTB17 CASR LYPD1 SULF2 PXDN ZKSCAN1 JAG1 RBAK BMPER ATP2A2 PCDH7 NOTCH1 NOTCH2 | 4.81e-07 | 423 | 109 | 13 | int:NOTCH2 |
| Interaction | PRG2 interactions | 3.40e-06 | 285 | 109 | 10 | int:PRG2 | |
| Interaction | ZSCAN21 interactions | 6.16e-06 | 128 | 109 | 7 | int:ZSCAN21 | |
| Interaction | NTN5 interactions | 7.91e-06 | 24 | 109 | 4 | int:NTN5 | |
| Interaction | ZFP41 interactions | 1.41e-05 | 57 | 109 | 5 | int:ZFP41 | |
| Interaction | FBXO2 interactions | FRAS1 GAS6 LRP1B SULF2 PXDN JAG1 SLC12A7 AGRN PCDH9 NOTCH1 NOTCH2 | 1.42e-05 | 411 | 109 | 11 | int:FBXO2 |
| Interaction | NXPH2 interactions | 2.94e-05 | 33 | 109 | 4 | int:NXPH2 | |
| Interaction | CACNA1A interactions | 5.54e-05 | 123 | 109 | 6 | int:CACNA1A | |
| Interaction | CFC1 interactions | 6.34e-05 | 126 | 109 | 6 | int:CFC1 | |
| Interaction | LGALS1 interactions | 8.06e-05 | 332 | 109 | 9 | int:LGALS1 | |
| Interaction | C2CD4B interactions | 9.30e-05 | 44 | 109 | 4 | int:C2CD4B | |
| Cytoband | 4p15 | 1.23e-04 | 7 | 112 | 2 | 4p15 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 9.97e-08 | 57 | 72 | 6 | 1179 | |
| GeneFamily | Non-clustered protocadherins | 1.12e-07 | 12 | 72 | 4 | 21 | |
| GeneFamily | Pappalysins|Sushi domain containing | 1.56e-05 | 2 | 72 | 2 | 897 | |
| GeneFamily | ATPases Ca2+ transporting | 5.53e-04 | 9 | 72 | 2 | 1209 | |
| GeneFamily | Low density lipoprotein receptors | 1.19e-03 | 13 | 72 | 2 | 634 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FRAS1 CRIM1 GAS6 KCP SVEP1 NELL1 ANOS1 EYS SRPX2 FBLN2 PXDN SLIT3 BMPER AGRN FBN3 | 5.40e-15 | 196 | 111 | 15 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | FRAS1 CRIM1 GAS6 KCP SVEP1 NELL1 ANOS1 EYS SRPX2 FBLN2 PXDN VCAN SLIT3 BMPER AGRN FBN3 | 4.66e-14 | 275 | 111 | 16 | M5884 |
| Coexpression | NABA_MATRISOME | PAPPA2 FRAS1 CRIM1 ISM1 GAS6 KCP ADAM30 ISM2 SVEP1 NELL1 ANOS1 EYS SRPX2 FBLN2 SULF2 PXDN CCBE1 LPA VCAN SLIT3 PAPPA BMPER PLOD2 MUC4 AGRN FBN3 | 1.22e-13 | 1026 | 111 | 26 | M5889 |
| Coexpression | NABA_MATRISOME | PAPPA2 FRAS1 CRIM1 ISM1 GAS6 KCP ADAM30 ISM2 SVEP1 NELL1 SRPX2 FBLN2 SULF2 PXDN CCBE1 LPA VCAN SLIT3 PAPPA BMPER PLOD2 MUC4 AGRN | 3.26e-11 | 1008 | 111 | 23 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FRAS1 CRIM1 GAS6 KCP SVEP1 NELL1 SRPX2 FBLN2 PXDN SLIT3 BMPER AGRN | 3.33e-11 | 191 | 111 | 12 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | FRAS1 CRIM1 GAS6 KCP SVEP1 NELL1 SRPX2 FBLN2 PXDN VCAN SLIT3 BMPER AGRN | 1.35e-10 | 270 | 111 | 13 | MM17057 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.33e-07 | 16 | 111 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.33e-07 | 16 | 111 | 4 | M2207 | |
| Coexpression | BMI1_DN.V1_UP | 3.16e-06 | 147 | 111 | 7 | M2782 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 3.45e-06 | 149 | 111 | 7 | M45703 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 4.08e-06 | 8 | 111 | 3 | M9884 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 5.19e-06 | 59 | 111 | 5 | M47993 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | DLL4 POLE PCDH11Y ISM2 TMEFF2 NELL1 ANOS1 LYPD1 SRPX2 CCBE1 PCDH11X ANKRD11 PAPPA NOTCH2 MAPK8IP2 LRRC71 | 7.51e-06 | 1035 | 111 | 16 | M9898 |
| Coexpression | SUNG_METASTASIS_STROMA_UP | 7.54e-06 | 110 | 111 | 6 | M9483 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 2.05e-05 | 131 | 111 | 6 | M39232 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 2.08e-05 | 355 | 111 | 9 | M45758 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 2.36e-05 | 200 | 111 | 7 | M5261 | |
| Coexpression | GSE42724_NAIVE_VS_B1_BCELL_UP | 2.36e-05 | 200 | 111 | 7 | M9790 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 2.64e-05 | 137 | 111 | 6 | M40313 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | SRPX2 SULF2 PXDN FRMD6 SUSD2 VCAN JAG1 ANKRD11 PAPPA PLOD2 NOTCH1 NOTCH2 | 3.25e-05 | 681 | 111 | 12 | M39175 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 3.76e-05 | 479 | 111 | 10 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 4.03e-05 | 483 | 111 | 10 | MM1082 | |
| Coexpression | DURAND_STROMA_S_UP | 4.27e-05 | 300 | 111 | 8 | M2581 | |
| Coexpression | DURAND_STROMA_S_UP | 4.69e-05 | 304 | 111 | 8 | MM1083 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | FLNB CRIM1 PRDM5 LYSMD3 FBLN2 PXDN ZKSCAN1 FRMD6 DIP2C KMT2A ATP2A2 MUC4 | 5.62e-05 | 721 | 111 | 12 | M1999 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 7.24e-05 | 417 | 111 | 9 | M39224 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | TNPO1 TLK2 PLB1 KAT6A ZFYVE1 ANOS1 VCAN ANKRD11 LRP1 AGRN NOTCH2 LRRC71 | 7.78e-05 | 746 | 111 | 12 | M40863 |
| Coexpression | DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS | 9.44e-05 | 56 | 111 | 4 | M40224 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 9.99e-05 | 174 | 111 | 6 | M45676 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.16e-04 | 59 | 111 | 4 | M47989 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.26e-04 | 261 | 111 | 7 | M1834 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 1.45e-04 | 267 | 111 | 7 | M12890 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 1.59e-04 | 25 | 111 | 3 | M9946 | |
| Coexpression | ALONSO_METASTASIS_EMT_DN | 1.76e-04 | 5 | 111 | 2 | M3029 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | FAT4 DLL4 KREMEN2 SVEP1 NELL1 LYPD1 FBLN2 SULF2 CCBE1 JAG1 PAPPA SLC12A7 PLOD2 NOTCH1 | 1.80e-04 | 1074 | 111 | 14 | M1941 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL | 1.88e-04 | 124 | 111 | 5 | M45673 | |
| Coexpression | GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP | 2.08e-04 | 199 | 111 | 6 | M5105 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_DN | 2.08e-04 | 199 | 111 | 6 | M4558 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.13e-04 | 200 | 111 | 6 | M5930 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 2.13e-04 | 200 | 111 | 6 | M9041 | |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | 2.26e-04 | 382 | 111 | 8 | M38972 | |
| Coexpression | RB_P107_DN.V1_UP | 2.34e-04 | 130 | 111 | 5 | M2802 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | PSD2 CRIM1 LRP1B INSYN2A TMEFF2 NELL1 PPARGC1A VCAN PCDH11X PAPPA PCDH7 PCDH9 TARBP1 MAPK8IP2 | 2.43e-04 | 1106 | 111 | 14 | M39071 |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_DN | 2.65e-04 | 73 | 111 | 4 | M1561 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_PROGENITORS_CELL | 2.79e-04 | 135 | 111 | 5 | M45710 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | 2.98e-04 | 504 | 111 | 9 | M2157 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 3.35e-04 | 32 | 111 | 3 | M5903 | |
| Coexpression | MEL18_DN.V1_UP | 3.40e-04 | 141 | 111 | 5 | M2784 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | 3.74e-04 | 312 | 111 | 7 | M39161 | |
| Coexpression | ZHONG_PFC_C4_PTGDS_POS_OPC | 4.12e-04 | 147 | 111 | 5 | M39099 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 4.38e-04 | 35 | 111 | 3 | MM17054 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 PRDM5 SVEP1 TMEFF2 PPARGC1A SRPX2 SULF2 PXDN VCAN JAG1 PCDH11X LRP1 PAPPA PLOD2 PCDH9 NOTCH2 | 1.61e-06 | 773 | 107 | 16 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | PAPPA2 TMEFF2 PPARGC1A FBLN2 SULF2 VCAN PCDH11X LRP1 PLOD2 PCDH9 NOTCH2 | 2.30e-06 | 364 | 107 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | GAS6 SVEP1 SRPX2 FBLN2 PXDN SUSD2 VCAN JAG1 SLIT3 LRP1 PAM PLOD2 | 2.54e-06 | 445 | 107 | 12 | GSM777043_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | PAPPA2 FRAS1 CRIM1 ISM1 VCAN JAG1 BMPER AGRN PCDH7 NOTCH1 NOTCH2 | 5.41e-06 | 398 | 107 | 11 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 PRDM5 SVEP1 TMEFF2 PPARGC1A FBLN2 SULF2 PXDN VCAN JAG1 PCDH11X LRP1 PLOD2 PCDH9 NOTCH2 | 7.07e-06 | 768 | 107 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | PAPPA2 FAT4 PSD2 CRIM1 ISM1 KCP LRP1B SVEP1 TMEFF2 NELL1 HAVCR1 LYPD1 FBLN2 FRMD6 SLIT3 PAPPA BMPER PCDH7 | 8.50e-06 | 1094 | 107 | 18 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | PAPPA2 FRAS1 CRIM1 POLE ISM1 PPARGC1A ZBED4 ZKSCAN1 VCAN JAG1 BMPER AGRN PCDH7 NOTCH1 NOTCH2 | 8.91e-06 | 783 | 107 | 15 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | TLK2 MGAM PMS2 PRDM5 LYSMD3 BIRC6 SVEP1 TLK1 FBLN2 SULF2 PCDH11X ANKRD11 LRP1 PLOD2 PCDH9 | 1.17e-05 | 801 | 107 | 15 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | PSD2 ISM1 NELL1 HAVCR1 LYPD1 SLIT3 PAPPA BMPER IGLON5 FBN3 MAPK8IP2 | 1.19e-05 | 433 | 107 | 11 | Arv_EB-LF_1000_K4 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.30e-05 | 437 | 107 | 11 | GSM777046_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | PAPPA2 PSD2 ISM1 CUBN SVEP1 TMEFF2 NELL1 HAVCR1 LYPD1 SRPX2 SLIT3 PAPPA BMPER PLOD2 FBN3 MAPK8IP2 | 2.18e-05 | 951 | 107 | 16 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | CRIM1 SVEP1 LYPD1 SRPX2 FBLN2 FRMD6 BST1 CCBE1 SUSD2 SLIT3 LRP1 PAM PAPPA BMPER PLOD2 PCDH9 | 2.95e-05 | 975 | 107 | 16 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#5_top-relative-expression-ranked_200 | 2.96e-05 | 71 | 107 | 5 | gudmap_developingKidney_e12.5_renal vesicle_200_k5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 2.99e-05 | 175 | 107 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FRAS1 POLE PRDM5 SVEP1 TMEFF2 PPARGC1A SULF2 CCBE1 VCAN JAG1 PCDH11X LRP1 PCDH9 NOTCH2 | 3.57e-05 | 777 | 107 | 14 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | PAPPA2 FAT4 PSD2 DLL4 ISM1 LRP1B SVEP1 NELL1 HAVCR1 ANOS1 LYPD1 SLIT3 PAPPA IGLON5 FBN3 MAPK8IP2 | 3.72e-05 | 994 | 107 | 16 | PCBC_EB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.14e-05 | 336 | 107 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.94e-05 | 195 | 107 | 7 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 7.58e-05 | 439 | 107 | 10 | GSM777059_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 8.01e-05 | 356 | 107 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | PAPPA2 FAT4 GAS6 SVEP1 NELL1 SULF2 FRMD6 VCAN PCDH11X LRP1 DIP2C PAM PCDH9 | 8.95e-05 | 740 | 107 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 9.30e-05 | 450 | 107 | 10 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 9.82e-05 | 453 | 107 | 10 | GSM777067_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.01e-04 | 147 | 107 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.02e-04 | 455 | 107 | 10 | GSM777055_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.20e-04 | 464 | 107 | 10 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | PAPPA2 DLL4 ISM1 KCP CUBN LRP1B SVEP1 NELL1 HAVCR1 LYPD1 SLIT3 PAPPA IGLON5 FBN3 MAPK8IP2 | 1.34e-04 | 992 | 107 | 15 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | FRAS1 CRIM1 GAS6 SVEP1 FBLN2 SULF2 BST1 SUSD2 PHF11 LRP1 PAM PLOD2 PCDH9 | 1.47e-04 | 778 | 107 | 13 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_200 | 1.66e-04 | 161 | 107 | 6 | gudmap_developingKidney_e12.5_renal vesicle_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.76e-04 | 310 | 107 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | POLE PRDM5 SVEP1 TMEFF2 PPARGC1A FBLN2 SULF2 VCAN PCDH11X LRP1 PLOD2 PCDH9 NOTCH2 | 1.77e-04 | 793 | 107 | 13 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.83e-04 | 104 | 107 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | PAPPA2 FAT4 GAS6 NELL1 PPARGC1A SULF2 FRMD6 CCBE1 VCAN PCDH11X LRP1 PAM PCDH9 | 1.86e-04 | 797 | 107 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.90e-04 | 165 | 107 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | PAPPA2 CRIM1 GAS6 PRDM5 SVEP1 FBLN2 FRMD6 CCBE1 SLIT3 LRP1 PAPPA BMPER MAPK8IP2 | 2.29e-04 | 814 | 107 | 13 | JC_fibro_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.44e-04 | 413 | 107 | 9 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_100 | 2.64e-04 | 25 | 107 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | PAPPA2 SVEP1 TMEFF2 PPARGC1A FBLN2 SULF2 PXDN VCAN PCDH11X LRP1 BMPER PLOD2 NOTCH2 | 2.67e-04 | 827 | 107 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.70e-04 | 249 | 107 | 7 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.21e-04 | 339 | 107 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 3.22e-04 | 182 | 107 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.59e-04 | 261 | 107 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.29e-04 | 354 | 107 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 4.53e-04 | 357 | 107 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 4.88e-04 | 361 | 107 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 5.02e-04 | 456 | 107 | 9 | GSM777032_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 5.60e-04 | 202 | 107 | 6 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.64e-04 | 369 | 107 | 8 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.86e-04 | 466 | 107 | 9 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.94e-04 | 284 | 107 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | PAPPA2 CRIM1 CUBN PPARGC1A AFM SUSD2 VCAN JAG1 SLIT3 ATP2A2 PLOD2 AGRN NOTCH2 | 6.27e-04 | 905 | 107 | 13 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | TLK2 MGAM PRDM5 LYSMD3 BIRC6 SVEP1 FBLN2 PCDH11X ANKRD11 LRP1 PLOD2 PCDH9 | 6.30e-04 | 790 | 107 | 12 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | FAT4 GAS6 KCP PRDM5 SVEP1 NELL1 PPARGC1A FBLN2 SULF2 FRMD6 BST1 VCAN SLIT3 BMPER PLOD2 | 6.32e-04 | 1148 | 107 | 15 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 6.64e-04 | 34 | 107 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.74e-04 | 138 | 107 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | PAPPA2 FAT4 GAS6 SULF2 FRMD6 CCBE1 VCAN PCDH11X LRP1 PAM PCDH7 PCDH9 | 6.81e-04 | 797 | 107 | 12 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 6.85e-04 | 291 | 107 | 7 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | TLK2 PAPPA2 MGAM CRIM1 LYSMD3 BIRC6 FBLN2 SLIT3 ANKRD11 LRP1 PLOD2 PCDH9 | 6.96e-04 | 799 | 107 | 12 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | MGAM BIRC6 FBXO30 DHX30 PPARGC1A TLK1 ZKSCAN1 AFM JAG1 ANKRD11 AGRN PCDH7 | 7.11e-04 | 801 | 107 | 12 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 7.82e-04 | 388 | 107 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_1000 | PSD2 ZBTB17 ISM1 EXOSC8 PRDM5 DHX30 NELL1 LYPD1 JAG1 ANKRD11 BMPER NOTCH1 | 8.10e-04 | 813 | 107 | 12 | gudmap_developingKidney_e12.5_renal vesicle_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_100 | 8.63e-04 | 84 | 107 | 4 | gudmap_kidney_P2_CapMes_Crym_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 9.25e-04 | 497 | 107 | 9 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 9.84e-04 | 87 | 107 | 4 | GSM777050_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.01e-03 | 311 | 107 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.05e-03 | 406 | 107 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_100 | 1.07e-03 | 89 | 107 | 4 | gudmap_kidney_P3_CapMes_Crym_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 1.08e-03 | 408 | 107 | 8 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200 | 1.16e-03 | 91 | 107 | 4 | gudmap_developingGonad_e14.5_ epididymis_200_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.17e-03 | 156 | 107 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | FAT4 SVEP1 INSYN2A TMEFF2 NELL1 SULF2 VCAN SLIT3 PAPPA BMPER PCDH9 | 1.19e-03 | 734 | 107 | 11 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.24e-03 | 42 | 107 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | PAPPA2 PSD2 ISM1 SVEP1 NELL1 HAVCR1 LYPD1 SLIT3 PAPPA BMPER IGLON5 FBN3 MAPK8IP2 | 1.31e-03 | 981 | 107 | 13 | Arv_EB-LF_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#2_top-relative-expression-ranked_100 | 1.34e-03 | 11 | 107 | 2 | gudmap_developingKidney_e15.5_cortic collect duct_100_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.35e-03 | 327 | 107 | 7 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 1.36e-03 | 95 | 107 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_500 | |
| CoexpressionAtlas | thyroid gland | 1.37e-03 | 240 | 107 | 6 | thyroid gland | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.38e-03 | 162 | 107 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | PAPPA2 CRIM1 GAS6 SVEP1 PPARGC1A RNF150 FBLN2 FRMD6 SLIT3 LRP1 PAM PAPPA PLOD2 | 1.42e-03 | 990 | 107 | 13 | JC_fibro_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | PAPPA2 FAT4 PSD2 ISM1 LRP1B SVEP1 NELL1 HAVCR1 LYPD1 SRPX2 SLIT3 PAPPA BMPER | 1.47e-03 | 994 | 107 | 13 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.50e-03 | 165 | 107 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 1.53e-03 | 98 | 107 | 4 | gudmap_kidney_P2_CapMes_Crym_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 1.53e-03 | 98 | 107 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.54e-03 | 166 | 107 | 5 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 1.58e-03 | 167 | 107 | 5 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.60e-03 | 337 | 107 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#1_top-relative-expression-ranked_200 | 1.72e-03 | 47 | 107 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_k1_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | FAT4 ISM1 FBXO30 TMEFF2 VCAN PCDH11X PAPPA BMPER AGRN PCDH7 PCDH9 | 1.78e-03 | 772 | 107 | 11 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.54e-11 | 190 | 112 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-09 | 189 | 112 | 9 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.33e-09 | 190 | 112 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-09 | 191 | 112 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-09 | 191 | 112 | 9 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-09 | 191 | 112 | 9 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-09 | 191 | 112 | 9 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-09 | 192 | 112 | 9 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-09 | 192 | 112 | 9 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-09 | 192 | 112 | 9 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.60e-09 | 194 | 112 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.68e-09 | 195 | 112 | 9 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-09 | 196 | 112 | 9 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-09 | 196 | 112 | 9 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-09 | 196 | 112 | 9 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.83e-09 | 197 | 112 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-09 | 197 | 112 | 9 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.83e-09 | 197 | 112 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.00e-09 | 199 | 112 | 9 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.00e-09 | 199 | 112 | 9 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.09e-09 | 200 | 112 | 9 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.09e-09 | 200 | 112 | 9 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-09 | 200 | 112 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-09 | 200 | 112 | 9 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.09e-09 | 200 | 112 | 9 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-09 | 200 | 112 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.09e-09 | 200 | 112 | 9 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.09e-09 | 200 | 112 | 9 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.09e-09 | 200 | 112 | 9 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-09 | 200 | 112 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-08 | 169 | 112 | 8 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-08 | 176 | 112 | 8 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-08 | 176 | 112 | 8 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-08 | 180 | 112 | 8 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-08 | 182 | 112 | 8 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-08 | 182 | 112 | 8 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-08 | 183 | 112 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-08 | 184 | 112 | 8 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.32e-08 | 185 | 112 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-08 | 187 | 112 | 8 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.63e-08 | 188 | 112 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-08 | 189 | 112 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.74e-08 | 189 | 112 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-08 | 190 | 112 | 8 | dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-08 | 190 | 112 | 8 | 0bb06df3d5a50416854370f234718c6cec3d773b | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-08 | 190 | 112 | 8 | 008290bb5c79446681dd6bf354336c57ad0d6f13 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-08 | 190 | 112 | 8 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-08 | 190 | 112 | 8 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-08 | 191 | 112 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-08 | 191 | 112 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-08 | 191 | 112 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.97e-08 | 191 | 112 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-08 | 192 | 112 | 8 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-08 | 192 | 112 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-08 | 192 | 112 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-08 | 193 | 112 | 8 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-08 | 193 | 112 | 8 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-08 | 193 | 112 | 8 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-08 | 193 | 112 | 8 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-08 | 193 | 112 | 8 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-08 | 193 | 112 | 8 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-08 | 193 | 112 | 8 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-08 | 193 | 112 | 8 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-08 | 193 | 112 | 8 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.35e-08 | 194 | 112 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-08 | 194 | 112 | 8 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-08 | 194 | 112 | 8 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.35e-08 | 194 | 112 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.35e-08 | 194 | 112 | 8 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-08 | 195 | 112 | 8 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.49e-08 | 195 | 112 | 8 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-08 | 195 | 112 | 8 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-08 | 195 | 112 | 8 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.63e-08 | 196 | 112 | 8 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-08 | 196 | 112 | 8 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.63e-08 | 196 | 112 | 8 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.63e-08 | 196 | 112 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-08 | 196 | 112 | 8 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-08 | 196 | 112 | 8 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-08 | 197 | 112 | 8 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-08 | 197 | 112 | 8 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.77e-08 | 197 | 112 | 8 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.77e-08 | 197 | 112 | 8 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.77e-08 | 197 | 112 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.77e-08 | 197 | 112 | 8 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-08 | 197 | 112 | 8 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.77e-08 | 197 | 112 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.77e-08 | 197 | 112 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.93e-08 | 198 | 112 | 8 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 3.93e-08 | 198 | 112 | 8 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-08 | 198 | 112 | 8 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-08 | 199 | 112 | 8 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-08 | 199 | 112 | 8 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-08 | 199 | 112 | 8 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-08 | 199 | 112 | 8 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.24e-08 | 200 | 112 | 8 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.24e-08 | 200 | 112 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.24e-08 | 200 | 112 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.24e-08 | 200 | 112 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.24e-08 | 200 | 112 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| Computational | Neighborhood of MMP11 | 1.80e-04 | 42 | 73 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.58e-04 | 46 | 73 | 4 | GNF2_TIMP2 | |
| Computational | Metal / Ca ion binding. | 2.77e-04 | 133 | 73 | 6 | MODULE_324 | |
| Computational | Neighborhood of KISS1 | 3.29e-04 | 49 | 73 | 4 | GNF2_KISS1 | |
| Drug | AC1L380G | 1.96e-06 | 19 | 111 | 4 | CID000084698 | |
| Disease | Adenoid Cystic Carcinoma | 1.99e-06 | 100 | 109 | 6 | C0010606 | |
| Disease | Hepatic ductular hypoplasia | 1.35e-05 | 2 | 109 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 1.35e-05 | 2 | 109 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1 | 1.35e-05 | 2 | 109 | 2 | C4012050 | |
| Disease | Alagille Syndrome 2 | 1.35e-05 | 2 | 109 | 2 | C1857761 | |
| Disease | Alagille Syndrome 1 | 1.35e-05 | 2 | 109 | 2 | C1956125 | |
| Disease | lung large cell carcinoma (biomarker_via_orthology) | 1.35e-05 | 2 | 109 | 2 | DOID:4556 (biomarker_via_orthology) | |
| Disease | lung small cell carcinoma (biomarker_via_orthology) | 1.35e-05 | 2 | 109 | 2 | DOID:5409 (biomarker_via_orthology) | |
| Disease | Alagille Syndrome | 1.35e-05 | 2 | 109 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 1.35e-05 | 2 | 109 | 2 | cv:C0085280 | |
| Disease | triglyceride measurement, alcohol drinking | 3.40e-05 | 99 | 109 | 5 | EFO_0004329, EFO_0004530 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 3.75e-05 | 101 | 109 | 5 | EFO_0004530, EFO_0007878 | |
| Disease | Brody myopathy (implicated_via_orthology) | 4.05e-05 | 3 | 109 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Hennekam syndrome (is_implicated_in) | 4.05e-05 | 3 | 109 | 2 | DOID:0060366 (is_implicated_in) | |
| Disease | Hennekam lymphangiectasia-lymphedema syndrome | 4.05e-05 | 3 | 109 | 2 | C0340834 | |
| Disease | sphingomyelin measurement | 8.03e-05 | 278 | 109 | 7 | EFO_0010118 | |
| Disease | lung adenocarcinoma (biomarker_via_orthology) | 8.07e-05 | 4 | 109 | 2 | DOID:3910 (biomarker_via_orthology) | |
| Disease | triglycerides in medium LDL measurement | 8.33e-05 | 62 | 109 | 4 | EFO_0022322 | |
| Disease | uric acid measurement | 9.02e-05 | 610 | 109 | 10 | EFO_0004761 | |
| Disease | esterified cholesterol measurement | 1.16e-04 | 128 | 109 | 5 | EFO_0008589 | |
| Disease | brain cancer (implicated_via_orthology) | 1.20e-04 | 26 | 109 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 1.34e-04 | 5 | 109 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.85e-04 | 30 | 109 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 2.01e-04 | 6 | 109 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | Adams Oliver syndrome | 2.01e-04 | 6 | 109 | 2 | C0265268 | |
| Disease | Congenital defect of skull and scalp | 2.01e-04 | 6 | 109 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome 1 | 2.01e-04 | 6 | 109 | 2 | C4551482 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 2.01e-04 | 6 | 109 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.04e-04 | 78 | 109 | 4 | EFO_0022187 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.61e-04 | 447 | 109 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Colorectal Carcinoma | 2.80e-04 | 702 | 109 | 10 | C0009402 | |
| Disease | homocitrulline measurement | 2.81e-04 | 7 | 109 | 2 | EFO_0021018 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.81e-04 | 7 | 109 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.81e-04 | 7 | 109 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | type 1 diabetes mellitus | 2.86e-04 | 242 | 109 | 6 | MONDO_0005147 | |
| Disease | lipid measurement, lipoprotein measurement | 3.53e-04 | 90 | 109 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | Ependymoblastoma | 3.73e-04 | 8 | 109 | 2 | C0700367 | |
| Disease | Neuroectodermal Tumor, Primitive | 3.73e-04 | 8 | 109 | 2 | C0206663 | |
| Disease | Cerebral Primitive Neuroectodermal Tumor | 3.73e-04 | 8 | 109 | 2 | C0751675 | |
| Disease | Spongioblastoma | 3.73e-04 | 8 | 109 | 2 | C0334584 | |
| Disease | Medulloepithelioma | 3.73e-04 | 8 | 109 | 2 | C0334596 | |
| Disease | heart disease (implicated_via_orthology) | 3.76e-04 | 38 | 109 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 4.33e-04 | 95 | 109 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | Prostatic Neoplasms | 4.75e-04 | 616 | 109 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.75e-04 | 616 | 109 | 9 | C0376358 | |
| Disease | hemangiopericytoma (is_marker_for) | 4.79e-04 | 9 | 109 | 2 | DOID:264 (is_marker_for) | |
| Disease | cancer (implicated_via_orthology) | 4.92e-04 | 268 | 109 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 5.06e-04 | 99 | 109 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 5.67e-04 | 102 | 109 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | Facies | 5.97e-04 | 10 | 109 | 2 | C0282631 | |
| Disease | pulse pressure measurement | PAPPA2 FLNB CRIM1 ATG7 DLGAP4 SVEP1 PPARGC1A ASAP2 JAG1 EIF4E SLIT3 ANKRD11 LRP1 MUSK | 6.15e-04 | 1392 | 109 | 14 | EFO_0005763 |
| Disease | Malignant neoplasm of salivary gland | 6.21e-04 | 45 | 109 | 3 | C0220636 | |
| Disease | Malignant neoplasm of breast | FLNB GFRAL DLL4 WDR88 CUBN SULF2 LLGL1 JAG1 DIP2C ATP2A3 NOTCH1 NOTCH2 | 6.22e-04 | 1074 | 109 | 12 | C0006142 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 6.55e-04 | 106 | 109 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 6.79e-04 | 107 | 109 | 4 | EFO_0004614, EFO_0004615 | |
| Disease | Salivary Gland Neoplasms | 7.06e-04 | 47 | 109 | 3 | C0036095 | |
| Disease | kidney cancer (implicated_via_orthology) | 7.28e-04 | 11 | 109 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 7.53e-04 | 110 | 109 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 7.53e-04 | 110 | 109 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 7.53e-04 | 110 | 109 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | body weight | PAPPA2 MGAM CRIM1 PRDM5 ZFYVE1 LRP1B TMEFF2 NELL1 EYS SLIT3 PAPPA PCDH7 EIF2AK3 | 7.76e-04 | 1261 | 109 | 13 | EFO_0004338 |
| Disease | free cholesterol measurement | 8.33e-04 | 113 | 109 | 4 | EFO_0008591 | |
| Disease | QT interval | 8.40e-04 | 534 | 109 | 8 | EFO_0004682 | |
| Disease | cortical thickness | FLNB CRIM1 PRDM5 NELL1 SULF2 VCAN JAG1 LRP1 KMT2A PAM PCDH7 MUSK | 8.48e-04 | 1113 | 109 | 12 | EFO_0004840 |
| Disease | QRS duration | 8.56e-04 | 298 | 109 | 6 | EFO_0005055 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 8.71e-04 | 12 | 109 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 8.71e-04 | 12 | 109 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 8.71e-04 | 12 | 109 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | Thromboembolism | 8.71e-04 | 12 | 109 | 2 | C0040038 | |
| Disease | antihyperlipidemic drug use measurement | 8.89e-04 | 115 | 109 | 4 | EFO_0803367 | |
| Disease | phospholipids in medium VLDL measurement | 9.50e-04 | 52 | 109 | 3 | EFO_0022154 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 9.78e-04 | 118 | 109 | 4 | EFO_0010119 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.00e-03 | 53 | 109 | 3 | C4707243 | |
| Disease | Connective Tissue Diseases | 1.03e-03 | 13 | 109 | 2 | C0009782 | |
| Disease | total lipids in medium VLDL | 1.06e-03 | 54 | 109 | 3 | EFO_0022153 | |
| Disease | eosinophil count | DNAH3 PLB1 KCP CASR SVEP1 PXDN CCBE1 JAG1 PHF11 ANKRD11 ATP2A3 MUSK NOTCH1 NOTCH2 | 1.17e-03 | 1488 | 109 | 14 | EFO_0004842 |
| Disease | triglycerides in large VLDL measurement | 1.18e-03 | 56 | 109 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 1.18e-03 | 56 | 109 | 3 | EFO_0022320 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 1.20e-03 | 14 | 109 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | fatty acid measurement | 1.20e-03 | 436 | 109 | 7 | EFO_0005110 | |
| Disease | triglycerides in VLDL measurement | 1.37e-03 | 59 | 109 | 3 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 1.37e-03 | 59 | 109 | 3 | EFO_0022301 | |
| Disease | Malignant neoplasm of skin | 1.37e-03 | 59 | 109 | 3 | C0007114 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 1.37e-03 | 59 | 109 | 3 | EFO_0022260 | |
| Disease | Skin Neoplasms | 1.37e-03 | 59 | 109 | 3 | C0037286 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.38e-03 | 15 | 109 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.38e-03 | 15 | 109 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.38e-03 | 15 | 109 | 2 | C0154091 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 1.40e-03 | 221 | 109 | 5 | C0011860 | |
| Disease | choline measurement | 1.40e-03 | 130 | 109 | 4 | EFO_0010116 | |
| Disease | total lipids in VLDL measurement | 1.44e-03 | 60 | 109 | 3 | EFO_0022314 | |
| Disease | free cholesterol in very large VLDL measurement | 1.51e-03 | 61 | 109 | 3 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 1.51e-03 | 61 | 109 | 3 | EFO_0022276 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.57e-03 | 16 | 109 | 2 | C0334634 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 1.58e-03 | 62 | 109 | 3 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 1.58e-03 | 62 | 109 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 1.58e-03 | 62 | 109 | 3 | EFO_0022299 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 1.66e-03 | 63 | 109 | 3 | EFO_0022292 | |
| Disease | laryngeal squamous cell carcinoma | 1.77e-03 | 17 | 109 | 2 | EFO_0006352 | |
| Disease | triglycerides in small LDL measurement | 1.81e-03 | 65 | 109 | 3 | EFO_0022323 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLDYQSCPTSEDCEN | 151 | Q10588 | |
| SCSADDYADLVFDCA | 1726 | Q6UB99 | |
| NYVKDEDLAGCSTAC | 1456 | Q9NR09 | |
| SYVGALCEQDTETCD | 3156 | P13611 | |
| DAAYNLQDSCLTDCD | 756 | Q9NZJ5 | |
| LAAALASCNESYGVC | 276 | P28332 | |
| ISLVEDVSSNYDGCC | 256 | P43652 | |
| GEYSDETDASACNKC | 571 | P41180 | |
| DSCSENQEPGYCTVS | 4076 | Q6V0I7 | |
| ERASCYNSALGCCSD | 1101 | O00468 | |
| YTGVDCELELSECDS | 316 | Q9NR61 | |
| CDEGTCTDKANILYA | 121 | P19021 | |
| NCKIYNDASCDISAD | 886 | Q9C0C7 | |
| SDCTLASAQCNEYSE | 996 | Q7L2E3 | |
| SDSSAACEDYRAGAC | 281 | Q75N90 | |
| SDQYEAACESACSEA | 476 | Q9Y2H0 | |
| ICALCNDSALDYNEA | 416 | Q93084 | |
| LEASGSVYICTLCDA | 721 | P15918 | |
| CLDYDGNILDACTFA | 141 | Q96B26 | |
| LSYRTGQDTANCDTC | 396 | Q6ZSG2 | |
| DYACPQCESSFTSED | 166 | Q9NQX1 | |
| ASVACEDYAETCLAC | 866 | Q15334 | |
| EDYAETCLACLTNLG | 871 | Q15334 | |
| SGFAAACVESCEVDN | 141 | P23352 | |
| SNCDGDSSCIYDTLA | 4911 | Q99102 | |
| EGSLDCIQLTNDYLC | 1276 | Q04721 | |
| TGHLCQYDVDECAST | 521 | P46531 | |
| GGECRQSEDYESFSC | 841 | P46531 | |
| ACVEQCLSSFYQDSG | 986 | Q86XX4 | |
| GSDEGYLCDECSLNN | 1166 | Q9NZR2 | |
| SREYICASDGCISAS | 3596 | Q9NZR2 | |
| EGDTLNAIALQYCCT | 71 | Q7Z3D4 | |
| ANGCSCLSEEDSQEY | 536 | Q5T1H1 | |
| NEYPCSCDADGTSTQ | 1061 | Q5T1H1 | |
| DSLAEAEGDYCAQLS | 371 | Q99456 | |
| TDGKTYDNRCALCAE | 121 | Q9NQ38 | |
| ESIAAGCLYNSTCDD | 2806 | Q07954 | |
| GSTALHYCCLTDNAE | 621 | O43150 | |
| CYPDENGASAENCTA | 966 | O43451 | |
| CLIGESFDDYSDDVC | 136 | P06730 | |
| TDDCGLGLSYDSDHC | 41 | Q13387 | |
| TCGAEDNDSCGISLY | 501 | P98095 | |
| ECSDNGDGTCSVSYL | 1086 | O75369 | |
| SGESSTLAAQHCCYD | 481 | Q6H9L7 | |
| NISIGSDHCSEYSCQ | 1036 | O60245 | |
| KLCAGASYAEENECF | 96 | Q9HC56 | |
| SVIAYAACCQLDSED | 261 | A0A1B0GTW7 | |
| YQCSGVLETDFAELC | 56 | Q8N4P6 | |
| VEAGYACFCGSESDL | 166 | Q8NCW0 | |
| INSSGCYSTVCVELD | 1716 | Q07864 | |
| LCSNCQAPYDSSAIE | 2186 | Q07864 | |
| SDNCTQECLIYGHSD | 1136 | Q9BZA7 | |
| YAIGSECATSCLDHN | 1496 | Q13219 | |
| SCALDLDSACSAITY | 551 | Q0VG06 | |
| QGDSAYCEDIDECAA | 426 | Q92832 | |
| TYSLSGESCIDIDEC | 586 | Q92832 | |
| DNGCTLCEFDTVDLS | 276 | O00469 | |
| GQICSSTDSDQCYLR | 421 | Q9UBK2 | |
| GAYQDCEETLAACQT | 1441 | Q92794 | |
| YECTNGFSLDSQCVL | 1606 | Q9BXP8 | |
| LCSADVNECEIYSGT | 166 | O60494 | |
| ELDEEGLYCNSCLAQ | 576 | Q96NE9 | |
| LAEYCDGNSSSCPND | 466 | Q9UKF2 | |
| ICALCNDSALDYNEA | 416 | P16615 | |
| NYTVCEGDNATLSCF | 41 | A6NGN9 | |
| ECAYDNLCQTEGVTA | 181 | O95352 | |
| DNGSSFLYDNCTACT | 246 | Q8N8U9 | |
| FDLQGSYNDSSCCAP | 3506 | Q8TD57 | |
| DLTCSGSDDCKAAYI | 266 | Q6UXV0 | |
| TSICYCASCEAEDLD | 101 | A8K830 | |
| CDALATYAAACQAAG | 1106 | Q9Y6R7 | |
| QNSHYELCADTCSLG | 3936 | Q9Y6R7 | |
| SQADLLDGCDVCSYD | 761 | Q96ST8 | |
| CLCDEGFAYSSQEKA | 221 | Q14393 | |
| YCLDIDECASSNGTL | 131 | Q6UXH8 | |
| DSYETQVRLTADGCC | 271 | Q9NZV1 | |
| CQALTQACGYTEAET | 521 | Q9Y2E4 | |
| EYCNLTQCSDAEGTA | 326 | P08519 | |
| YCNLTQCSDAEGTAV | 441 | P08519 | |
| EYCNLTQCSDAEGTA | 896 | P08519 | |
| TDSCIQFQTDSLGYC | 591 | Q5TB80 | |
| CASSAACLIASAGYQ | 71 | Q8N2G4 | |
| SNAECPACYESNGTS | 121 | Q6UX82 | |
| RQCALCLTYGDDSAN | 1871 | Q03164 | |
| ECDTHCGLDTARQEY | 221 | Q4AE62 | |
| CDLNTSSYDTSALCN | 271 | Q8TB52 | |
| LFCNGSQPSAACDEY | 341 | Q9Y666 | |
| ESTTLAAQHCCYGDN | 376 | B1AKI9 | |
| EEASDNCTQECLIYG | 1126 | Q9BZA8 | |
| FTGTYCHENINDCES | 621 | P78504 | |
| TESDFDNCAVCIEGY | 271 | Q9ULK6 | |
| CCYTADGTQLLTADS | 366 | Q9UGT4 | |
| CDNGYSLAGAETSTC | 751 | Q9UGT4 | |
| CSGYDDRENDLFLCD | 56 | Q9UIK5 | |
| GSSADACLCDALEAY | 1446 | Q6ZWJ8 | |
| TIENTAVSDSGVYCC | 91 | Q96D42 | |
| TCSCLRHGENYDDNS | 86 | Q53H47 | |
| LIGGSDLCDYCTDSN | 856 | Q6P1J6 | |
| SEHASCLNVDGSYIC | 1756 | Q4LDE5 | |
| DTDSFCTVLEYCEGN | 536 | Q86UE8 | |
| YSGKLCETDNDDCVA | 1066 | O75094 | |
| TDTFCTVLEYCEGND | 531 | Q9UKI8 | |
| CEDCGKAFSYNSSLL | 736 | O14709 | |
| CVDDTKLLSGSYDCT | 111 | Q6ZMY6 | |
| TNGVLLDSRCDYSCS | 136 | O60687 | |
| RYCQCNPDDSTSEDG | 391 | Q9BQI7 | |
| ECSECGKFSQLYLTD | 486 | Q9NYW8 | |
| DSGEYACSATNNIDS | 406 | Q92626 | |
| SSGILCCDVSSDNQY | 411 | A0A1W2PR48 | |
| CLLYSSGLVECEDQD | 71 | Q9UIL8 | |
| LCSLLDSEDYNTCEG | 141 | Q92973 | |
| VCEEYGLSCSDALHN | 251 | P54278 | |
| SYACSGTDEAIFECD | 21 | Q9HBF4 | |
| CQDYLSSSGLCSQET | 416 | A8K0R7 | |
| LYACDSCGDKFLDAN | 716 | Q13105 | |
| SCSSSYLVLACEDGV | 421 | Q6P2C0 | |
| YTCQDCGALFSQSAS | 306 | Q9Y2P0 | |
| CDECGKSYSQSSALL | 521 | Q6P9A1 | |
| DCFSYGEENLKTSIC | 1231 | Q13395 | |
| YECNECGKAFSQSSD | 461 | P17029 | |
| SEACTCDSGDYKLSL | 501 | Q8IWU5 | |
| ACDYVPSCLDGFSNN | 111 | Q5VZQ5 | |
| CSALLDVSQVDCDYS | 766 | O75132 | |
| ILSVEDSDDGIYCCT | 86 | O15146 |